Advanced Immune Therapeutic Strategies (AIT Strategies) is a biomedical firm specializing in translational immunology, clinical development, regulatory strategy and product development. We are innovators in the field of "indirect immunization", a terminology introduced by our founder Dr. Christopher Nicodemus. We work with academic collaborators, biotechnology companies and contract research organizations to facilitate development of novel therapies in cancer and other therapeutic areas.
Pandemic Preparedness. The Covid -19 pandemic was a milestone event for modern society. AIT Strategies commented in real time about the nature and threat of the pandemic and barriers to front line experimental field studies created by the modern clincal research process. The concerns encountered then still apply and thus the Covid 19 tab on this website remains for the historical record.
You have reached the home page of Advanced Immune Therapeutic Strategies -- AIT Strategies
Immune complexes processed by dendritic cells